The leading provider of aesthetic medical services in China, Aesthetic Medical International Holdings Group Limited, officially reported its unaudited financial results for the Q3 and nine months ended September 30, 2020.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Fiscal results for the Q3 ended September 30, 2020
Net sales amounted to $41.4 million, an 18.2 percent rise from $36.19 million in the third quarter of 2019.
Gross profit was $26.5 million, up from $24.99 million in the third quarter of 2019, a rise of 9.4 percent.
The operating margin was 63.9%, a 5.2 percentage point decline from 69.1% in the third quarter of 2019.
The deficit for the year was $2.6 million compared with a benefit in the third quarter of 2019 of $18.07 million.
For the year, EBITDA1 was US$1.0 million, a 95.4 percent decline from $23.01 million in the third quarter of 2019.
For the year, Adjusted Profit1 was US$1.0 million, a 65.8 percent decline from $3.07 million in the third quarter of 2019.
For the year, adjusted EBITDA1 was US$4.6 million, a 39.1 percent decline from $7.86 million in the third quarter of 2019.
Compared with basic earnings per share of $ 0.41 in the third quarter of 2019, the basic loss per share was $ 0.04. Compared with the diluted loss per share of 0.018 in the third quarter of 2019, the diluted loss per share was $ 0.04.
Fiscal results for the nine months ended September 30, 2020
Net sales was 79.4 million dollars, a 14.6 percent decline from 95.9 million dollars in the same period in 2019.
Gross profit was 45.6 million dollars, a 28.1 percent decline from 65.4 million dollars in the same period in 2019.
The gross margin was 57.5 percent, a decline from 68.3 percent in the same timeframe in 2019 of 10.8 percentage points.
Losses were $24.3 million during the year, relative to a benefit of $30.25 million in the same period in 2019.
EBITDA1 was a loss of $14.4 million for the year, a decline of 133.1 percent from a profit in the same period of 2019 of $44.98 million.
For the $9.13 period, Adjusted Profit1 was a loss of $12.1 million, a drop of 237.5 percent from a million profit in the same period of 2019.
For the year, adjusted EBITDA1 was a loss of $2.2 million, a 109.9 percent decline from a benefit of $23.3 million in the same period of 2019.
In contrast to basic earnings per share of $ 0.71 in the same period in 2019, basic loss per share was $ 0.36. Compared with adjusted earnings per share of $0.033 in the same period in 2019, the diluted loss per share was $0.36.
